Great West Life Assurance CO Exelixis, Inc. Transaction History
Great West Life Assurance CO
- $53.1 Billion
- Q2 2024
A detailed history of Great West Life Assurance CO transactions in Exelixis, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 224,505 shares of EXEL stock, worth $6.45 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
224,505
Previous 171,672
30.78%
Holding current value
$6.45 Million
Previous $4.07 Million
23.97%
% of portfolio
0.01%
Previous 0.01%
Shares
27 transactions
Others Institutions Holding EXEL
# of Institutions
466Shares Held
239MCall Options Held
2.04MPut Options Held
1.29M-
Black Rock Inc. New York, NY33.5MShares$963 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.7MShares$852 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA27.1MShares$779 Million2.95% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.2MShares$436 Million0.6% of portfolio
-
State Street Corp Boston, MA12.6MShares$362 Million0.01% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $9.25B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...